Search
for

    Sort by

    Research 391–420 of 1000+

    1. The Efficacy and Psychoneuroimmunology Mechanism of Camouflage Combined With Psychotherapy in Vitiligo Treatment Frontiers in Medicine · 2022 · 7 citations
    2. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial 2023 · 6 citations
    3. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial EClinicalMedicine · 2021 · 6 citations
    4. Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis Pharmacological Research · 2024 · 5 citations
    5. Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial medRxiv (Cold Spring Harbor Laboratory) · 2021 · 5 citations
    6. Biologics in the management of childhood atopic dermatitis 2023 · 4 citations
    7. CFTR potentiator ivacaftor protects against noise-induced hair cell loss by increasing Nrf2 and reducing oxidative stress Biomedicine & Pharmacotherapy · 2023 · 4 citations
    8. Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis Journal of Infection · 2022 · 4 citations
    9. Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review Frontiers in Oncology · 2024 · 3 citations
    10. The Effect of Oral Care Foams and a Spray on Salivary pH Changes after Exposure to Acidic Beverages in Young Adults Dentistry Journal · 2024 · 3 citations
    11. Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials Journal of dermatological treatment · 2023 · 3 citations
    12. Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial EClinicalMedicine · 2021 · 3 citations
    13. Tolerability of Six Months Indirect Cold (Physical) Plasma Treatment of the Scalp for Hair Loss Journal of Drugs in Dermatology · 2020 · 3 citations
    14. Feasibility and acceptability of an online multicomponent very low-carbohydrate intervention in young adult women with obesity: a pilot study Pilot and Feasibility Studies · 2024 · 2 citations
    15. Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19 Frontiers in Nutrition · 2022 · 2 citations
    16. A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata Indian Journal of Dermatology, Venereology and Leprology · 2021 · 2 citations
    17. Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study. Journal of Clinical Oncology · 2016 · 2 citations
    18. Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3 International Journal of Dermatology · 2025 · 1 citations
    19. Fish Acellular Dermal Matrix Promotes Repair of Full‐Thickness Skin Defects in Mice and Bama Pigs Wound Repair and Regeneration · 2025 · 1 citations
    20. A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol Skin Health and Disease · 2025 · 1 citations
    21. Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata CPT Pharmacometrics & Systems Pharmacology · 2025 · 1 citations
    22. Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China Advances in therapy · 2023 · 1 citations
    23. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study Journal of the European Academy of Dermatology and Venereology · 2021 · 1 citations
    24. LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor Journal of Investigative Dermatology · 2021 · 1 citations
    25. The Evolving Role for Autologous Adipose Tissue (Fat) in Treating Hair Loss Hair transplant forum international · 2018 · 1 citations
    26. A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA). Journal of Clinical Oncology · 2017 · 1 citations
    27. A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss. PubMed · 2016 · 1 citations
    28. Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study. PubMed · 2016 · 1 citations
    29. Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A Randomized, Controlled, Pilot Study Dermatologic Surgery · 2025
    30. The Additive Effect of Platelet-Rich Plasma in the Treatment of Actively Bleeding Peptic Ulcer Clinical Endoscopy · 2021